<DOC>
	<DOCNO>NCT00279903</DOCNO>
	<brief_summary>Patients painful knee osteoarthritis randomly allocate one three group . Each group receive knee injection : 1 ) cortisone , 2 ) low dose Botox , 3 ) high dose Botox . Patients follow 6 month see significant pain relief improvement activity level injection .</brief_summary>
	<brief_title>Is Botox Effective Relieving Pain From Knee Osteoarthritis ?</brief_title>
	<detailed_description>Abstract Botulinum toxin type A ( Btx-A ) extensively study use clinically muscle paralyze effect , grow body evidence support role pain modulation . Symptomatic osteoarthritis lead cause pain , functional impairment , disability , significant indirect cost society . Preliminary evidence suggest Btx-A significant nociceptive effect , inject intra-articularly , painful joint . The propose study evaluate efficacy safety Btx-A inject intra-articularly 60 subject moderate pain functional impairment secondary knee osteoarthritis , randomize , cortisone-controlled , double blind study , 6 month follow period . If Btx-A show equal great efficacy cortisone patient population , may excellent second line treatment osteoarthritis , multiple joint , surgery contraindicate deferred due age , comorbidities , patient preference . Further study examine mechanism action biochemical level , clinical effect Btx-A joint ( osteoarthritis inflammatory arthritis ) , efficacy Btx-A compare hyaluronic acid ( currently available injectable alternative cortisone ) , side effect profile ( effect adjacent muscle strength , joint position sense , long-term outcome ) would indicate .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Cortisone acetate</mesh_term>
	<mesh_term>Cortisone</mesh_term>
	<criteria>Inclusion criterion : 1 . A history knee joint pain great 6 month . 2 . Medial lateral tibiofemoral joint line tenderness . 3 . Unilateral knee pain 6/10 great , average , visual analog scale ( VAS ) , interfere function day per week . 4 . Prior fail treatment acetaminophen and/or non steroidal antiinflammatory medication , physical therapy ( quadriceps strengthening ) . 5 . Kellgren grade II III radiographic change osteoarthritis . Exclusion criterion : 1 . Age le 40 year . 2 . Anticoagulation warfarin heparin . 3 . Known allergy sensitivity component study medication . 4 . Body mass index great 35 . 5 . Previous major reconstructive surgery affect knee . 6 . Previous arthroscopic surgery affect knee past 12 month . 7 . History crystal induce arthropathy . 8 . Use aminoglycoside antibiotic , curarelike agent , history neuromuscular disease myasthenia gravis , amyotrophic lateral sclerosis , myopathy . 9 . History evidence active rheumatologic disease , diabetes , severe peripheral neuropathy , clinically evident cardiac respiratory disease interfere functional status , serious disease , include psychiatric disorder . 10 . Evidence recent alcohol drug abuse , history medication misuse addiction . 11 . Females pregnant , breastfeeding , plan pregnancy study , think may pregnant start study , female childbearing potential unable unwilling use reliable form contraception study . 12 . Intraarticular ( knee ) systemic steroid past 6 month , intraarticular knee hyaluronic acid injection past 6 month . 13 . Patients rate average daily pain le 6 10 point VAS scale screen visit . 14 . Concurrent participation another investigational drug device study participation 30 day immediately prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>